What’s News in Markets: Wegovy Pill, Salesforce AI Woes, BlackRock Record

17 Jan 2026 · 5 min · 3 chapters

Ask about this episode

Ask anything about it. ChatGPT or Claude reads this page and answers with the times it was said.

Connect VO and ask about every podcast you hear, including the moments you saved. Add to ChatGPT · Add to Claude

In short

WSJ What’s News Podcast Episode Summary

Episode Details

  • Title: What’s News in Markets: Wegovy Pill, Salesforce AI Woes, BlackRock Record
  • Host: Jack Pitcher
  • Release Date: Saturday, January 17
  • Description: The episode discusses the significant stock movements of the week, focusing on Novo Nordisk’s Wegovy pill launch, challenges faced by software companies like Salesforce, and BlackRock's record asset management.

Key Themes

  • Market Sentiment Amidst Regulatory Scrutiny
  • Jerome Powell Investigation:
  • Federal Reserve Chair Jerome Powell is under investigation by U.S. prosecutors regarding his testimony on a Fed renovation project.
  • Powell describes the investigation as a tactic by President Trump to influence Fed independence and interest rate policy.
  • Investor concerns revolve around potential inflation risks if Fed independence is compromised.
  • Earnings Season Overview:
  • Banks released mixed earnings results:
  • JP Morgan: Lower-than-expected investment banking revenue.
  • Goldman Sachs & Morgan Stanley: Reported strong financial performance.

Stock Market Highlights

  • Stock Index Performance for the Week:
  • S&P 500: Down 0.4%
  • Dow Jones Industrial Average: Down 0.3%
  • Nasdaq Composite: Down 0.7%

Key Company Insights Novo Nordisk (Wegovy Pill)

  • Wegovy Launch:
  • The U.K. health regulator approved a higher dose for patients with a BMI of at least 30.
  • U.S. sales started recently, with over 4,000 new prescriptions reported in the first week.
  • Stock Performance:
  • Shares of Novo Nordisk increased by 9% on the announcement and closed up 6% for the week.

Salesforce and Software Sector Concerns

  • Investor Anxiety Around AI:
  • Major software companies like Intuit, Salesforce, and Adobe faced declines in stock prices despite no specific negative news.
  • Concerns arise over AI advancements potentially disrupting their market positions.
  • Stock Performance:
  • Intuit: Down 16%
  • Salesforce: Down 13%
  • Adobe: Down 11%

BlackRock

  • Record Assets Under Management:
  • BlackRock reported a record $14 trillion in assets, driven by market gains and $700 billion in new client investments.
  • Stock Performance:
  • Shares rose nearly 6% following the earnings report, closing near a record high.

Conclusion

  • The podcast episode encapsulates a turbulent week for the stock market, emphasizing the impact of regulatory scrutiny, emerging AI technologies on software firms, and notable successes in the pharmaceutical and investment sectors.

For more in-depth information on the week’s market movements, visit [WSJ.com](https://www.wsj.com).

--- Production Credits:

  • Produced by Jess Fenton
  • Supervising Producer: Melanie Roy

Feel free to explore more episodes for further insights on market trends.

Written by AI. May contain mistakes. Listen to the episode to check what was said.

Chapters

Tap a time to open that second in VO

Federal Reserve Investigation and Market Reactions

0:45 to 1:55

Discussion on Jerome Powell's investigation and its implications for investors.

“Investors, concerned that a lack of Fed independence could lead to runaway inflation, have been closely watching the Powell situation.”

Earnings Season Highlights

1:55 to 3:05

Overview of mixed earnings reports from major banks and their impact on stocks.

“Novo's American depository receipts jumped 9 % Friday and closed up 6 % for the week.”

Wegovy's Market Performance

3:05 to 3:49

Analyzing the strong market response to Novo Nordisk's Wegovy drug news.

“BlackRock reported a record $14 trillion in assets under management on Thursday, and investors were pleased with fee growth that beat expectations.”
Hear the part that matters, and keep it.Open this episode in VO. Double tap your headphones to save a moment as you listen.
Get VO free

Transcript

Automatic transcript. May contain errors.

0:02Hey, listeners. It's Saturday, January 17. I'm Jack Pitcher for The Wall Street Journal, and this is What's News in Markets, our look at the biggest stock moves of the week and the news that drove them. Let's get to it. Calm in the face of chaos. That was the theme for markets this week. On Sunday night, news broke that Federal Reserve Chair Jerome Powell is being investigated by U.S. prosecutors over his testimony about the central bank's building renovation project. In a video statement, Powell, who is usually quite restrained, called the investigation a pretext as part of President Trump's campaign to pressure the Fed to lower interest rates and end the independence of the central bank.

0:46Investors, concerned that a lack of Fed independence could lead to runaway inflation, have been closely watching the Powell situation. Meanwhile, banks kicked off earnings season with a mixed bag of results. JP Morgan disappointed investors with lower-than-expected investment banking revenue. But Goldman Sachs and Morgan Stanley posted strong quarters. At the index level, stocks inched lower for the week. The S &P 500 ended down 0.4%, just shy of a record high. The Dow fell 0.3%, while the Nasdaq composite was 0.7 % lower.

1:24Novo Nordisk shares jumped in the U.S. on Friday after a string of positive news about its flagship weight loss drug, Wagovi. The U.K.'s health regulator approved a significantly higher dose of the drug for patients with a body mass index of at least 30. The Danish drugmaker is awaiting regulatory approvals for the same size dose in the U.S. and the EU. Meanwhile, sales of Novo's Wagovi pill just began in the U.S. Data released Friday showed the new pill generated more than 4 ,000 new prescriptions in the U.S. last week. A strong start, analysts said. Novo's American depository receipts jumped 9 % Friday and closed up 6 % for the week.

2:08AI is causing investor angst over the outlook for some major software companies. Intuit, the maker of TurboTax, Salesforce, a corporate software titan, and Adobe, which makes Photoshop and Acrobat, were all among the worst performers in the S &P 500 this week. None of the companies reported specific bad news, but analysts say rapid advancements in AI are creating a general sense of unease around software companies that were once thought to be invincible thanks to the widespread adoption of their products. AI is becoming very adept at coding software. Some investors now picture a future in which companies can use AI to handle tasks once outsourced to enterprise software.

2:49or simply build their own. For the week, Intuit shares fell 16%. Salesforce was 13 % lower, while Adobe dropped 11%.

3:01The world's biggest investment firm keeps getting bigger. BlackRock reported a record $14 trillion in assets under management on Thursday, and investors were pleased with fee growth that beat expectations. BlackRock primarily makes money through fees it charges to manage trillions of dollars for clients. Its assets grew to a record in 2025 on the back of market gains and$700 billion of new client money. BlackRock shares advanced almost 6 % after it reported earnings Thursday and closed the week near a record high. And now you know what's news in markets this week. You can read more about the week's market moves on wsj.com.

3:41Today's show is produced by Jess Fenton with supervising producer Melanie Roy. I'm Jack Pitcher. Have a great weekend.

From the publisher

Why are investors buzzing about Novo Nordisk’s Wegovy pill launch? And how has sentiment turned against software makers like Salesforce? Plus, what drove BlackRock’s asset pile to a record $14 trillion? Host Jack Pitcher discusses the biggest stock moves of the week and the news that drove them.

Sign up for the WSJ's free Markets A.M. newsletter.

Learn more about your ad choices. Visit megaphone.fm/adchoices

More from WSJ What’s News

All 335 episodes
What’s News in Markets: Wegovy Pill, Salesforce AI Woes, BlackRock RecordWSJ What’s News · 5 min
Listen in VO